Novo Resources Corp. March Quarterly Update

Go back to Novo Resources Corp. March Quarterly Update

Buy the dip in this major pharma stock - Citi

May 6, 2024 9:30 AM EDT

Citi analysts said in a note Monday that they believe history shows the dip in one major pharmaceutical company's shares should be bought.

The investment bank said Novo Nordisk (NYSE: NVO) remains Buy-rated, while the firm also maintained a Dkr975.00 price target on the stock.... More